Methods for measuring proteasome activity: current limitations and future developments.
The proteasome has been validated as a therapeutic target, with proteasome inhibitors showing particular efficacy in the treatment of Multiple Myeloma. A wide range of methods have been developed to profile proteasome activity. These include the current method of choice fluorogenic peptide substrates, as well as bioluminescent imaging, immunological methods, and more recently, site-specific fluorescent probes. The aim of this review is to evaluate the currently available methods for profiling proteasome activity and their suitability for use in translational studies. Ongoing development of techniques for profiling proteasome activity will facilitate future research into proteasome-related pathologies, thus accelerating the development of more specific drug regimes.
Liggett
A
A
Centre for Cancer Research and Cell Biology, Queen's University, Belfast, Belfast, UK.
Crawford
L J
LJ
Walker
B
B
Morris
T C M
TC
Irvine
A E
AE
D004796:Clinical Enzyme Tests / Q000379:methods* / Q000639:trends; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005544:Forecasting; D006801:Humans; D008722:Methods; D046988:Proteasome Endopeptidase Complex / Q000032:analysis / Q000378:metabolism*; D061988:Proteasome Inhibitors
D004791:Enzyme Inhibitors; D061988:Proteasome Inhibitors; D046988:Proteasome Endopeptidase Complex